Abstract 4455: DNA methylation as biomarkers to predict early recurrence of T1-2N0 lung cancer
Chen Chen(Central South University), Malcolm V. Brock(Johns Hopkins University), Andrew Yang(Johns Hopkins University), Peng Huang(Johns Hopkins University), Zhihao Lü(Nanjing Tech University), James G. Herman(UPMC Hillman Cancer Center), Stephen B. Baylin(Johns Hopkins University), Tza‐Huei Wang(Johns Hopkins University), Devlin Danielle(Johns Hopkins University), Fenglei Yu(Central South University), Alicia Hulbert(Johns Hopkins University), Candace Griffin(Johns Hopkins University), Kristen Rodgers(Johns Hopkins University), Richard J. Battafarano(Johns Hopkins University), Beverly Lee(Lovelace Respiratory Research Institute)
Cited by 0
Related Papers
Inactivation of the DNA-Repair Gene<i>MGMT</i>and the Clinical Response of Gliomas to Alkylating Agents
|New England Journal of Medicine|2000|2.2k
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
|New England Journal of Medicine|2018|2.1k
Incidence and functional consequences of <i>hMLH1</i> promoter hypermethylation in colorectal carcinoma
|Proceedings of the National Academy of Sciences|1998|1.9k